Clinical features, mutational landscape and their prognostic impact in Chinese paediatric patients with T‐cell lymphoblastic lymphoma
British Journal of Haematology · 2025-11 · 207 (5) · 1994-2005
DOI: 10.1111/bjh.70097 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 16.09.2025. Verfasst von Yang Li und 18 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Diagnostics Laboratory, Beijing Gobroad Boren Hospital, Beijing, China. Hauptthemen laut MEDLINE: Mutation, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
T‐cell lymphoblastic lymphoma (T‐LBL) is an aggressive lymphoma that primarily affects children and young adults, and a comprehensive understanding of its molecular features is crucial for improving patient outcomes. In this study, 552 patients were included, with targeted next‐generation sequencing of 262 lymphoma‐associated genes performed on tumour samples from 119 patients. The associations between mutations and survival rates, as well as relapse and other clinical factors, were analysed. The results demonstrated that pleural effusion (PE) invasion was significantly associated with adverse event‐free survival (EFS) and overall survival (OS) ( p < 0.05). Additionally, we identified 92 genes with recurrent mutations, among which NOTCH1 (44%), FBXW7 (28%), PHF6 (11%), KRAS (10%) and NRAS (10%) were the most frequently altered. Patients with NOTCH1 mutations exhibited improved EFS and OS ( p < 0.01), whereas those carrying CREBBP , PTEN and LYST mutations exhibited worse prognosis ( p < 0.05). In conclusion, NOTCH1 mutations are associated with a favourable prognosis in paediatric T‐LBL, while CREBBP , PTEN and LYST mutations, as well as PE invasion, are linked to poor prognosis. This study identifies key molecular and clinical factors in paediatric T‐LBL progression, aiding high‐risk patient identification and personalized treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Diagnostics Laboratory, Beijing Gobroad Boren Hospital, Beijing, China.
- Medical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
- Department of Hematology/Oncology, Zhengzhou Children's Hospital, Zhengzhou, China.
- Department of Pediatric Lymphoma, Beijing Gobroad Boren Hospital, Beijing, China.
- Department of Pediatrics, Peking University People's Hospital, Beijing, China.
- Department of Pediatric Hematology/Oncology, Shandong University Affiliated Hospital (Jinan Children's Hospital), Jinan, China.
ORCID-Profile: Yang Li, Ling Jin, Keyan Yang, Xiaomei Yang, Rong Liu, Qinlong Zheng, Yonghong Zhang
Zitieren
APA
Li, Y., Jin, L., Liu, W., Liu, Y., Yang, K., Jia, Y., Yang, X., Dai, Y., Yang, L., Liu, R., Jiang, L., Zheng, M., Xu, J., Liu, A., Sun, L., Gao, H., Jin, R., Zheng, Q., & Zhang, Y. (2025). Clinical features, mutational landscape and their prognostic impact in Chinese paediatric patients with T‐cell lymphoblastic lymphoma. British Journal of Haematology, 207(5), 1994-2005. https://doi.org/10.1111/bjh.70097
Vancouver
Li Y, Jin L, Liu W, Liu Y, Yang K, Jia Y, et al. Clinical features, mutational landscape and their prognostic impact in Chinese paediatric patients with T‐cell lymphoblastic lymphoma. British Journal of Haematology. 2025;207(5):1994-2005. doi:10.1111/bjh.70097
BibTeX
@article{Li2025,
author = {Li, Yang and Jin, Ling and Liu, Wei and Liu, Ying and Yang, Keyan and Jia, Yueping and Yang, Xiaomei and Dai, Yunpeng and Yang, Lihua and Liu, Rong and Jiang, Lian and Zheng, Mincui and Xu, Jinzhong and Liu, Ansheng and Sun, Lirong and Gao, Hui and Jin, Runming and Zheng, Qinlong and Zhang, Yonghong},
title = {Clinical features, mutational landscape and their prognostic impact in Chinese paediatric patients with T‐cell lymphoblastic lymphoma},
journal = {British Journal of Haematology},
year = {2025},
volume = {207},
number = {5},
pages = {1994--2005},
doi = {10.1111/bjh.70097}
}
EUVIMED